Pharmaceutical manufacturing and biopharmaceutical company.
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2026 | PENN AVENUE PARTNERS |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— |
| Firm | Filings | Expenses |
|---|---|---|
| PENN AVENUE PARTNERS | 36 | — |
| Issue | Activities |
|---|---|
| Pharmacy | 36 |
| Budget/Appropriations | 10 |
| Medicare/Medicaid | 3 |